The COVID-19 pandemic has confirmed the strategic rationale underlying many hospital and health system mergers and acquisitions and may be acting as a catalyst for innovative strategic partnerships and tactical transactions, according to a new report by management consultancy KaufmanHall.

The report looks at key M&A trends as the pandemic compels health care organizations to focus on core business strengths, build partnerships and strengthen intellectual capital resources.

With respect to building partnerships, it says the COVID-19 crisis “should encourage healthcare leaders, federal and state legislators, and government agencies to reevaluate gaps in the nation’s healthcare infrastructure and recognize the value of building new partnerships to support a healthcare system that can provide high-quality care, accessible to all.”

Related News Articles

Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Chairperson's File
Public
Although hospitals and health systems are facing many pressures and challenges, now is the time to truly transform how we care for our patients and communities…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…